文献速递小儿眼科与斜弱视角膜与眼表疾病

社交媒体干预与先天性晶状体异位术后随访:一项随机临床试验

Social Media Interventions and Postoperative Follow-Up in Congenital Ectopia Lentis: A Randomized Clinical Trial.
PubMed 文献 · JAMA Ophthalmol · 2025-01-01

这项随机临床试验在中山眼科中心纳入110例因先天性晶状体异位(CEL)拟行晶状体手术的患儿家庭,比较微信电话提醒与健康教育(社交媒体组55例)与标准护理组(55例)的术后随访依从性。结果显示社交媒体组术后3个月随访出席率显著高于标准护理组(83.6% vs 41.8%;RR 2.05,95%CI 1.53-2.75;P<.001)。

要点

  • 社交媒体组术后3个月随访出席率83.6%(46/55),标准护理组41.8%(23/55),RR 2.05(95%CI 1.53-2.75;P<.001)。
  • 术后1个月出席率社交媒体组81.8%(45/55)vs 标准护理组58.2%(32/55);术后1周92.7%(51/55)vs 87.3%(48/55)。
  • 社交媒体组父母CEL知识准确率提高10.6%(95%CI 7.8%-13.5%),弱视治疗率RR 2.40(95%CI 1.26-4.56)。

核心结论

  • 基于社交媒体智能手机应用的干预显著提高了CEL患儿家庭的术后随访依从性并增加了父母知识。
  • 作者认为将移动健康技术整合到标准护理中可改善具有全身风险的进行性儿科疾病的管理,最终改善临床结局。

研究设计与样本

  • 随机临床试验,2022年12月至2024年10月在中山眼科中心(中国广州一家三级眼科医院)开展。
  • 纳入因CEL拟行晶状体手术的患儿家庭,随机分为社交媒体干预组和标准护理组,共110例患儿,每组55例。
  • 社交媒体组在术后1周、1个月和3个月预定预约前通过智能手机应用接受电话提醒和健康教育。
  • 主要结局为术后3个月随访出席情况。

主要发现

  • 社交媒体组术后3个月随访出席率83.6%(46/55),标准护理组41.8%(23/55)。
  • 术后3个月随访依从性干预组显著高于标准护理组(RR 2.05;95%CI 1.53-2.75;P<.001)。
  • 术后1个月出席率社交媒体组81.8%(45/55)vs 标准护理组58.2%(32/55);术后1周92.7%(51/55)vs 87.3%(48/55)。
  • 社交媒体组父母CEL知识准确率提高10.6%(95%CI 7.8%-13.5%),弱视治疗率RR 2.40(95%CI 1.26-4.56)。

关键数值与推荐

  • 社交媒体组55例(平均[SD]年龄6.9[2.8]岁;男性32例[58.2%]),标准护理组55例(平均[SD]年龄7.3[3.4]岁;男性32例[58.2%])。
  • 术后3个月随访出席率社交媒体组83.6%(46/55)vs 标准护理组41.8%(23/55),RR 2.05(95%CI 1.53-2.75;P<.001)。
  • 父母CEL知识准确率提高10.6%(95%CI 7.8%-13.5%);弱视治疗率RR 2.40(95%CI 1.26-4.56)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Congenital ectopia lentis (CEL), often associated with systemic diseases such as Marfan syndrome, requires rigorous postoperative follow-up to reduce the risk of severe complications. However, follow-up rates are frequently suboptimal, indicating an urgent need for effective interventions to improve adherence. OBJECTIVE: To assess the effect of WeChat (Tencent Holdings Ltd), a social media smartphone communication application, in delivering phone reminders and health education to improve postoperative follow-up adherence among families of children with CEL. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from December 2022 to October 2024. The study was conducted at the Zhongshan Ophthalmic Center, a tertiary ophthalmic hospital in Guangzhou, China. Families with children scheduled for lens surgery due to CEL were enrolled and randomized into the social media intervention group and the standard-care group. INTERVENTIONS: Parents in the social media intervention group received phone reminders and health education via the smartphone application before scheduled appointments at 1 week, 1 month, and 3 months after surgery. MAIN OUTCOMES AND MEASURES: The primary outcome was follow-up attendance at 3 months after surgery. RESULTS: A total of 110 children were included in this study, 55 in the social media group (mean [SD] age, 6.9 [2.8] years; 32 male [58.2%]) and 55 in the standard-care group (mean [SD] age, 7.3 [3.4] years; 32 male [58.2%]). The intervention group exhibited higher attendance rates than the standard-care group across all 3 postoperative follow-ups (3 months: 83.6% [46 of 55] vs 41.8% [23 of 55]; 1 month: 81.8% [45 of 55] vs 58.2% [32 of 55]; 1 week: 92.7% [51 of 55] vs 87.3% [48 of 55]). Follow-up adherence at 3 months was significantly higher in the intervention group compared with the standard-care group (relative risk [RR], 2.05; 95% CI, 1.53-2.75; P < .001). In addition, the intervention group showed greater improvements in parental CEL knowledge accuracy (10.6%, 95% CI, 7.8%-13.5%) and higher rates of amblyopia treatments (RR, 2.40; 95% CI, 1.26-4.56). CONCLUSIONS AND RELEVANCE: Results of this randomized clinical trial reveal that social media smartphone application-based interventions significantly improved follow-up adherence and increased parental knowledge among families of children with CEL. These findings suggest that integrating mobile health technologies into standard care can enhance the management of progressive pediatric conditions with systemic risks, ultimately improving clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05628129.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ma Y, Zhang X, Jin L, et al. Social Media Interventions and Postoperative Follow-Up in Congenital Ectopia Lentis: A Randomized Clinical Trial. JAMA Ophthalmol. 2025. PMID: 40208617. doi:10.1001/jamaophthalmol.2025.0526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。